Differentiating tunnel and abscess/inflammatory nodule recurrence refines surgical outcomes after wide excision in patients ...

STAFFORD, Texas, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, ...

The MarketWatch News Department was not involved in the creation of this content. STAFFORD, Texas, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a ...

Over five years, subsequent reoperation rates for single-level lumbar discectomy reached 14.4%, according to a study published in Spine. Four things to know: 1. The study included 308,979 adult ...

The US FDA approved 46 new drugs in 2025, despite a tumultuous year at the regulatory agency.

Gilead Sciences, Inc. (Nasdaq: GILD) and Assembly Biosciences, Inc. (Nasdaq: ASMB), today announced Gilead has exercised its combined option to exclusively license Assembly Bio’s herpes simplex virus ...

For women with a specific type of breast cancer known as HER2-positive (HER2+), any residual (leftover) disease after primary ...

Sabrina Karl has over two decades of experience writing about savings, CDs, and other banking topics. She is currently a full-time staff writer at Investopedia and one of the country's top experts on ...

The UK unemployment rate rose to 5.1% in the three months to October, with younger workers particularly affected, official data shows. This time last year the unemployment rate was 4.3%, illustrating ...

Simply sign up to the UK employment myFT Digest -- delivered directly to your inbox. The UK unemployment rate rose to 5.1 per cent and wage growth slowed in the three months to October as employers ...

Gilead Sciences GILD recently announced that it has exercised its combined option to exclusively license Assembly Biosciences’ ASMB herpes simplex virus (HSV) helicase-primase inhibitor programs. The ...